Since the diagnosis of TRAPS, the patient has started anti-IL-1 therapy with anakinra 100 mg daily, with marked improvement in systemic symptoms and normalization of inflammatory markers. This evidence concerns the gene IL1B and TNF receptor 1-associated periodic fever syndrome.